Evidence map›Paper›PMID 22941116›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2013

Somatic symptoms in cancer patients trajectory over 12 months and impact on functional status and disability.

Kurt Kroenke, Shelley A Johns, Dale Theobald, Jingwei Wu, Wanzhu Tu

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03905876 (Psychological Experience of the End of the Treatment During a Clincal Trial of the Early Phase and Role of the Initial prédispositions), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03905876 nacompletednot on this mapstarted 2019, after this paper: background citation

Psychological Experience of the End of the Treatment During a Clincal Trial of the Early Phase and Role of the Initial prédispositions ( VRAIMENT)

TypeinterventionalSponsorInstitut du Cancer de Montpellier - Val d'AurelleRan2019 to 2024Enrolled182ConditionsPsychological Distress, CancerArmsQuestionnaire
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2020
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Identifying the trajectory of SPPADE symptoms in patients with cancer using electronic health record data.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  6. Review
  7. Pain or fatigue: which correlates more with suffering in hospitalized cancer patients?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Risk of malnutrition and emotional distress as factors affecting health-related quality of life in patients with resected cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Observational
  13. Article
  14. Article
  15. Relationship among symptom clusters, quality of life, and treatment-specific optimism in patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  16. Article
  17. Article
  18. Effects of web-based interventions on cancer patients' symptoms: review of randomized trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Review
  19. A Guide to Inpatient Cancer Rehabilitation: Focusing on Patient Selection and Evidence-Based Outcomes.PM & R : the journal of injury, function, and rehabilitation · 2017
    Review
  20. Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kurt KroenkeVA HSR&D Center of Excellence for Implementing Evidence-Based Practice, Regenstrief Institute, Indianapolis, IN 46202, USA. kkroenke@regenstrief.org
Shelley A Johns
Dale Theobald
Jingwei Wu
Wanzhu Tu
Indiana University – Purdue University Indianapolis · USRegenstrief Institute · US

Funding

TeleCare Management of Pain and Depression in CancerR01CA115369 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KROENKE, KURT · 2005 to 2009
$2.1M
NCI NIH HHS R01 CA-115369NCI NIH HHS R01 CA115369
6 · The paper itself

Abstract

purposeCross-sectional studies have established the prevalence and functional impairment of somatic symptoms in cancer patients. The purpose of this study was to determine the trajectory and adverse consequences of such symptoms over time.

methodsSecondary analysis of longitudinal data from 405 cancer patients enrolled in a telecare management trial for pain and/or depression. Somatic symptom burden was measured with a 22-item scale at baseline, 1, 3, 6, and 12 months. Outcomes included the SF-12 Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, the Sheehan Disability Scale (SDS) score, and self-reported total disability days. Mixed methods repeated measures analyses were conducted to determine whether antecedent change in somatic symptom burden predicted functional status and disability.

resultsSymptoms were highly prevalent at baseline, with 15 of the 22 symptoms endorsed by more than half of the patients. A rather constant cross-sectional prevalence over 12 months at the group level belied a quite different trajectory at the patient level where the median persistence, resolution, and incidence rates for 14 of the most common symptoms were 39%, 37%, and 24%, respectively. A clinically significant (i.e., five points) reduction in somatic symptom burden predicted improvement in PCS, MCS, and SDS (all P < 0.001), as well as a lower likelihood of ≥14 disability days in the past 4 weeks (odds ratio, 0.84; 95% CI, 0.74 to 0.95).

conclusionsSomatic symptoms remain burdensome in cancer patients over 12 months and symptom improvement predicts significantly better functional status and less disability.

Indexed as

Persons with DisabilitiesQuality of LifeAdultAgedAged, 80 and overCross-Sectional StudiesDepressionDisability EvaluationFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedNeoplasmsPain

Identifiers

PMID22941116
PMCPMC3543758
OpenAlexW2040223239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.